Planned Parenthood Southwest Ohio Region v. DeWine, No. 17-3866 (6th Cir. 2019)Annotate this Case
A 2004 Ohio statute regulated the "off-label" prescription of mifepristone (RU-486), which is commonly used in conjunction with misoprostol, to induce first-trimester abortions without surgery. Planned Parenthood challenged the statute under 42 U.S.C. 1983. The Sixth Circuit affirmed a preliminary injunction “insofar as it prohibits unconstitutional applications of the [statute].” In 2006, the district court entered a permanent injunction. After the Ohio Supreme Court answered certified questions, the Sixth Circuit remanded for a determination regarding the injunction’s scope. In 2011, the district court clarified that the statute was enjoined only as it applied to instances where the health of the patient was at risk and denied broader relief, leaving one remaining claim. In 2016, the FDA amended its approval and label for mifepristone, authorizing the off-label uses at issue. The statute remains in force, requiring physicians to prescribe medication abortion according to the FDA’s updated approval. Planned Parenthood sought $10,365.35 to cover costs for litigation on the merits and attorneys’ fees at 2016 rates to offset lost interest. Using this rate, the requested fees for the preliminary injunction litigation totaled $372,164.63. The district court granted that request, finding the requested hours and rates reasonable. The Sixth Circuit affirmed, rejecting arguments that Planned Parenthood does not properly qualify as a “prevailing party” because its relief was narrow and preliminary; that the court erred in refusing to apply a blanket fee reduction based on the degree of success; and that the court erred in applying 2016 rates rather than 2006 rates The court properly engaged in a contextual, case-specific review, considered the aims of section 1988, and adequately explained its rationale.